Singapore Airshow: major exhibitors pull out amid coronavirus concern

1 / 3
Members of China’s People's Liberation Army Air Force watch an aerial display by their Ba Yi Aerobatics team during a media preview of the Singapore Airshow. (Reuters)
2 / 3
A view of the ST Engineering booth being set up during a media preview of the Singapore Airshow. (Reuters)
3 / 3
There have been 40 confirmed coronavirus cases in Singapore, which raised the threat level from the epidemic to the same put in place during the 2003 Severe Acute Respiratory System outbreak. (Reuters)
Short Url
Updated 09 February 2020

Singapore Airshow: major exhibitors pull out amid coronavirus concern

  • Major exhibitors including Lockheed Martin and Raytheon have pulled out over the virus
  • Show requiring temperature checks on arrival and is discouraging attendees from shaking hands

SINGAPORE: More than 70 trade exhibitors have pulled out of the Singapore Airshow amid concerns over the new coronavirus and the number of public tickets available will be less than half of those on offer in 2018 to limit attendance, the show’s organizer said on Sunday.
Some major exhibitors, including Lockheed Martin Corp. and Raytheon Co. have pulled out over the virus.
Experia Events Managing Director Leck Chet Lam told reporters the number of companies not attending represented less than 8 percent of those that had signed up for the show, to be held from Feb. 11 to 16.
He said the number of aircraft on static display would be lower than in 2018, but around 40 to 45 were still expected.
At a media preview at the show site on Sunday, there were some empty spaces where stands would have been assembled by some of the exhibitors that had pulled out.
The show is requiring temperature checks on arrival and is discouraging attendees from shaking hands as part of enhanced health measures to protect against the virus, Leck said.
There have been 40 confirmed coronavirus cases in Singapore, which on Friday raised the threat level from the epidemic to the same put in place during the 2003 Severe Acute Respiratory System outbreak.


UAE-led research recommends low risk cancer patients delay surgery amid COVID-19 crisis

Updated 07 April 2020

UAE-led research recommends low risk cancer patients delay surgery amid COVID-19 crisis

  • Report recommends each case still be considered for their individual needs
  • Low risk patients might be asked to consider delaying surgery

DUBAI: A global team of cancer treatment specialists, led by an Emirati physician, has published the first international medical recommendations for treating cancer patients during the coronavirus, COVID-19, pandemic, which in some cases suggests surgery should be delayed, UAE state news agency WAM reported.

Led by Humaid Al-Shamsi, consultant of oncology and cancer diseases, and associate professor at the University of Sharjah and President of the Emirates Cancer Society, the study was funded by the Khalifa bin Zayed Al Nahyan Foundation and Roche.

Mohammed Haji Al Khouri, director-general of the Khalifa bin Zayed Al Nahyan Foundation, said supporting scientific research, especially during the current crisis, is one of the Foundation’s priorities.

“We have seen the dangers that cancer patients across the world are facing during the current coronavirus pandemic, as well as the absence of any international recommendations for treating them during the crisis,” Al Khouri  said.

“That is why we decided to bring together international experts to make recommendations as soon as possible, to establish a global reference for all cancer therapists.”

The study concluded that each case should be considered on their own individual needs, but this should include postponing surgery or chemotherapy for low risk patients, as well as minimizing outpatient visits.

Healthcare company, Roche, renewed its commitment to supporting scientific research and commended the determination shown by researchers, doctors and international pharmaceutical companies to curb COVID-19.